OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Emerging Relevance of AIM2 in Liver Disease
Beatriz Lozano‐Ruiz, José M. González‐Navajas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6535-6535
Open Access | Times Cited: 38
Beatriz Lozano‐Ruiz, José M. González‐Navajas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6535-6535
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Role of the Inflammasome in Liver Disease
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 178
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 178
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk
Ke Liu, Shiyun Tang, Chenhao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 27
Ke Liu, Shiyun Tang, Chenhao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 27
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 64
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 64
The role of pyroptosis in hepatocellular carcinoma
Zhimiao Zou, Minghui Zhao, Yang Yang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 811-823
Closed Access | Times Cited: 27
Zhimiao Zou, Minghui Zhao, Yang Yang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 811-823
Closed Access | Times Cited: 27
Exposure to DEHP induces testis toxicity and injury through the ROS/mTOR/NLRP3 signaling pathway in immature rats
Yifan Hong, Yu Zhou, Lianju Shen, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 227, pp. 112889-112889
Open Access | Times Cited: 54
Yifan Hong, Yu Zhou, Lianju Shen, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 227, pp. 112889-112889
Open Access | Times Cited: 54
Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease
Lu Xu, Jingyang Zhou, Jinhui Che, et al.
AJP Gastrointestinal and Liver Physiology (2021) Vol. 320, Iss. 6, pp. G1034-G1044
Closed Access | Times Cited: 53
Lu Xu, Jingyang Zhou, Jinhui Che, et al.
AJP Gastrointestinal and Liver Physiology (2021) Vol. 320, Iss. 6, pp. G1034-G1044
Closed Access | Times Cited: 53
EMT and Inflammation: Crossroads in HCC
Burcu Şengez, Brian I. Carr, Hani Alotaibi
Journal of Gastrointestinal Cancer (2022) Vol. 54, Iss. 1, pp. 204-212
Closed Access | Times Cited: 24
Burcu Şengez, Brian I. Carr, Hani Alotaibi
Journal of Gastrointestinal Cancer (2022) Vol. 54, Iss. 1, pp. 204-212
Closed Access | Times Cited: 24
FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease
Lin Li, Lina Kong, Shuai Xu, et al.
Hepatology International (2024) Vol. 18, Iss. 1, pp. 188-205
Closed Access | Times Cited: 4
Lin Li, Lina Kong, Shuai Xu, et al.
Hepatology International (2024) Vol. 18, Iss. 1, pp. 188-205
Closed Access | Times Cited: 4
Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications
Lili Yu, Feifei Gao, Yaoxin Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116724-116724
Open Access | Times Cited: 4
Lili Yu, Feifei Gao, Yaoxin Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116724-116724
Open Access | Times Cited: 4
Inflammation and gut microbiota in the alcoholic liver disease
Yan Gao
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420020-9420020
Closed Access | Times Cited: 4
Yan Gao
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420020-9420020
Closed Access | Times Cited: 4
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
Siyuan Yang, Yunyi Zou, Chun Zhong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Siyuan Yang, Yunyi Zou, Chun Zhong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation
Fernando Lucas‐Ruiz, Sandra V. Mateo, Marta Jover-Aguilar, et al.
EBioMedicine (2022) Vol. 87, pp. 104419-104419
Open Access | Times Cited: 16
Fernando Lucas‐Ruiz, Sandra V. Mateo, Marta Jover-Aguilar, et al.
EBioMedicine (2022) Vol. 87, pp. 104419-104419
Open Access | Times Cited: 16
AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3
Hua Ye, Wenwen Yu, Yunlei Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
Hua Ye, Wenwen Yu, Yunlei Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation
Yan Qin, Pan Liu-xian, Tianyu Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Yan Qin, Pan Liu-xian, Tianyu Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Effects of AIM2 and IFI16 on Infectious Diseases and Inflammation
Fan Zhen, Rui Chen, Wen Yin, et al.
Viral Immunology (2023) Vol. 36, Iss. 7, pp. 438-448
Closed Access | Times Cited: 7
Fan Zhen, Rui Chen, Wen Yin, et al.
Viral Immunology (2023) Vol. 36, Iss. 7, pp. 438-448
Closed Access | Times Cited: 7
A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma
Feifan He, Zhongming He, Caoye Wang
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101532-101532
Open Access | Times Cited: 2
Feifan He, Zhongming He, Caoye Wang
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101532-101532
Open Access | Times Cited: 2
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer
Ruby Dawson, Brendan J. Jenkins
Immune Network (2024) Vol. 24, Iss. 5
Open Access | Times Cited: 2
Ruby Dawson, Brendan J. Jenkins
Immune Network (2024) Vol. 24, Iss. 5
Open Access | Times Cited: 2
Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
Shuang Liu, Ruonan Shao, Xiaoyun Bu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Shuang Liu, Ruonan Shao, Xiaoyun Bu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review
Wenxing He, Can-Li Xu, Dewen Mao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5473-5494
Closed Access | Times Cited: 5
Wenxing He, Can-Li Xu, Dewen Mao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5473-5494
Closed Access | Times Cited: 5
Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein
Lutong Ren, Huijie Yang, Hongbo Wang, et al.
Phytomedicine (2024) Vol. 131, pp. 155758-155758
Closed Access | Times Cited: 1
Lutong Ren, Huijie Yang, Hongbo Wang, et al.
Phytomedicine (2024) Vol. 131, pp. 155758-155758
Closed Access | Times Cited: 1
Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages
Jiajia Xu, Xiaoyan Cheng, Qi Wang, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 1
Jiajia Xu, Xiaoyan Cheng, Qi Wang, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 1
20(S)-Protopanaxatriol ameliorates MAFLD by inhibiting NLRP3 inflammasome
Bingjie Lu, Dan Wang, Dong Xie, et al.
European Journal of Pharmacology (2022) Vol. 940, pp. 175468-175468
Open Access | Times Cited: 7
Bingjie Lu, Dan Wang, Dong Xie, et al.
European Journal of Pharmacology (2022) Vol. 940, pp. 175468-175468
Open Access | Times Cited: 7
Research and progress of inflammasomes in nonalcoholic fatty liver disease
Ke-qian Chen, Bo-yi Ke, Lu Cheng, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110013-110013
Closed Access | Times Cited: 3
Ke-qian Chen, Bo-yi Ke, Lu Cheng, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110013-110013
Closed Access | Times Cited: 3
Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease
Shuai Xu, Lina Kong, Lin Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166930-166930
Closed Access | Times Cited: 3
Shuai Xu, Lina Kong, Lin Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166930-166930
Closed Access | Times Cited: 3
Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma
Zeyu Zhang, Fada Xia, Zhijie Xu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Zeyu Zhang, Fada Xia, Zhijie Xu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
